Fibrinogen preparations enriched in fibrinogen with an extended alpha chain

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9694054
SERIAL NO

14877354

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to fibrinogen preparations enriched in α-extended fibrinogen. Compositions comprising such preparations show improved clotting properties compared to preparations based on HMW Fib which typically contain no or only low amounts of α-extended fibrinogen. In particular, clot formation time and the clot strength of a clot made by α-extended fibrinogen are improved. In addition, plasmin-mediated degradation of α-extended fibrinogen is reduced as compared to plasma derived fibrinogen.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MALLINCKRODT PHARMA IP TRADING D A CDAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN 15

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bout, Abraham Moerkapelle, NL 84 1515
Grimbergen, Joseph Lisse, NL 7 1
Koopman, Jacob Leiderdorp, NL 10 32

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 4, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 4, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00